Pfizer Inc.
Pfizer Global Medical Grants (GMG), and Merck KGaA, Darmstadt, Germany - Global Medical Education & Academic Organization Relations (Global MedEd & AOR) are collaborating to provide grant support for continuing professional education and patient education in the area of Immuno-Oncology. Immuno-Oncology is a priority for Merck KGaA, Darmstadt, Germany and Pfizer Inc, and for the Global Strategic Alliance among our organizations.
The intent of this RFP is to support independent education initiatives for healthcare professionals involved in the treatment of patients with locally-advanced or metastatic urothelial carcinoma (mUC), incl. oncologists, urologists, and specialty nurses. Patient education programs designed to specifically reach patients with urothelial carcinoma and their caregivers are also in scope for this RFP.
Grant application due date: April 12, 2022